l carnitine injections with hypothyroidism Compounded (L) Injection Exploring the potential anti-thyroid activity
Description
Most of the proteins are targeted for proteasomal degradation after being covalently modified with ubiquitin, a small protein with 76 amino acids, which is conjugated through the formation of an isopeptide bond between the -amino group of a lysine residue of the substrate and the COOH-terminal carboxylate (343)
Retatrutide is supplied here strictly as a research compound and is not TGA-approved for human use
Dosage should begin at 50 mg/kg/day
